Table 1.
Characteristics of included studies
References | Year | Location | Total | triple therapy | Probiotic | Day | Blind | Placebo | Jaded scores |
---|---|---|---|---|---|---|---|---|---|
Mohamed H. Emara [4] | 2014 | Egypt | 70 | Omeprazole amoxicillin clarithromycin | Lactobacillus reuteri | 14 | double-blind | Y | 5 |
Ruggiero Francavilla [5] | 2014 | Italy | 100 | PPI amoxicillin clarithromycin | Lactobacillus reuteri | 7 | double-blind | Y | 5 |
Tomás Navarro-Rodriguez [6] | 2013 | Brazilian | 107 | Lansoprazole furazolidone, tetracycline | Lactobacillus acidophilus Lactobacillus rhamnosus ifidobacterium bifidum Streptococcus faecium | 7 | double-blind | Y | 5 |
Homayoun Zojaji [7] | 2013 | Iran | 160 | omeprazole amoxicillin clarithromycin | saccaromyces boularidi | 14 | - | N | 1 |
Yi-Qi Du [8] | 2012 | China | 234 | Omeprazole amoxicillin clarithromycin | Lactobacillus acidophilus Streptococcus faecalis Bacillus subtilis (B. subtilis) | 7 | open | N | 3 |
V Mirzaee [9] | 2012 | Iran | 102 | Pantoprazole amoxicillin clarithromycin | probiotic yogur | 7 | - | Y | 2 |
J. A. da Silva Medeiros [10] | 2011 | Portugal | 62 | Esomeprazole amoxicillin clarithromycin | L. acidophilus | 8 | double-blind | N | 2 |
Onder Bekar [11] | 2011 | Turkey | 82 | Lansoprazole amoxicillin clarithromycin | kefir | 14 | double-blind | Y | 5 |
Ryuzo Deguchi [12] | 2011 | Japan | 229 | Rabeprazole amoxicillin clarithromycin | yogurt (L. gasseri OLL2716) | 7 | - | N | 2 |
Min Jun Song [13] | 2010 | Korea | 661 | Omeprazole amoxicillin clarithromycin | S. boulardii | 7 | - | N | 3 |
Mi Na Kim [14] | 2008 | Korea | 347 | PPI amoxicillin clarithromycin | L. acidophilus HY 2177, L. casei HY 2743, B. longum HY 8001, S. thermophilus B-1 | 7 | 0pen | N | 3 |
G. SCACCIANOCE [15,16] | 2008 | Italy | 48 | Lansoprazole amoxicillin clarithromycin | Lactobacillus plantarum L. reuteri Lactobacillus casei subsp. Rhamnosus Bifidobacterium infantis Bifidobacterium longum Lactobacillus salivarius Lactobacillus acidophilus Streptococcus termophilus Lactobacillus sporogenes (Lactobacillaceae) | 7 | open | N | 3 |
sung keun park [16] | 2007 | Korea | 352 | Omeprazole amoxicillin clarithromycin | Bacillus subtilis, streptococcus faecium | 7 | - | N | 3 |
Nicola de Bortoli [17] | 2007 | Italy | 206 | Esomeprazole amoxicillin clarithromycin | Lactobacillus plantarum, L. reuterii L. caseisubsp. rhamnosus, Bifidobacterium infantis and B. longum, L. salivarius, L. acidophilus Streptococcus termophilus, L. sporogenes (Lactobacillaceae blf) | 7 | open | N | 3 |
Mehmet Cindoruk [18] | 2007 | Turkey | 124 | Lansoprazole amoxicillin clarithromycin | S. boulardii | 14 | double-blind | Y | 5 |
Witold Ziemniak [19] | 2006 | Poland | 245 | PPI amoxicillin clarithromycin | Lactobacillus acidophilus Lactobacillus rhamnosus | 10 | - | N | 2 |
E. MYLLYLUOMA [20] | 2005 | Finland | 47 | Lansoprazole amoxicillin clarithromycin | LGG L. rhamnosus P. freudenreichii ssp. shermanii JS B. breve | 7 | double-blind | Y | 5 |
E. C.NISTA [21] | 2004 | Italy | 120 | rabeprazole amoxicillin clarithromycin | B. clausii, Enterogermina | 7 | double-blind | Y | 5 |
B. -S.SHEU [22] | 2002 | Taiwan | 160 | Lansoprazole amoxicillin clarithromycin | Lactobacillus-andBifidobacterium-containing yogurt | 7 | - | N | 2 |
Filippo Cremonini [23] | 2002 | Italy | 85 | Rabeprazole clarithromycin tinidazole | Group 1 Lactobacillus casei subsp. rhamnosus (GG) Group 2 Saccharomyces boulardii Group 3 Lactobacillus acidophilus | 7 | Triple Blind | Y | 5 |
A. ARMUZZ [24] | 2001 | Italy | 60 | Rabeprazole clarithromycin tinidazole | Lactobacillus GG | 7 | double-blind | Y | 5 |
A. Armuzzi [26] | 2001 | Italy | 120 | Pantoprazole clarithromycin tinidazole | Lactobacillus GG | 7 | open | N | 3 |
F. CANDUCCI [25] | 2000 | Italy | 120 | Rabeprazole amoxicillin clarithromycin | Lactobacillus acidophilus strain LB | 7 | open | N | 3 |